Back to Search Start Over

Outcomes following upfront radiation versus monitoring in atypical meningiomas: 16-year experience at a tertiary medical center.

Authors :
Pan PC
Pisapia DJ
Ramakrishna R
Schwartz TH
Pannullo SC
Knisely JPS
Chiang GC
Ivanidze J
Stieg PE
Liechty B
Brandmaier A
Fine HA
Magge RS
Source :
Neuro-oncology advances [Neurooncol Adv] 2021 Jun 29; Vol. 3 (1), pp. vdab094. Date of Electronic Publication: 2021 Jun 29 (Print Publication: 2021).
Publication Year :
2021

Abstract

Background: The role of postoperative upfront radiotherapy (RT) in the management of gross totally resected atypical meningiomas remains unclear. This single-center retrospective review of newly diagnosed histologically confirmed cases of World Health Organization (WHO) Grade II atypical meningioma at Weill Cornell Medicine from 2004 to 2020 aims to compare overall survival (OS) and progression-free survival (PFS) of postoperative upfront RT versus observation, stratified by resection status (gross total resection [GTR] vs subtotal resection [STR]).<br />Methods: Ninety cases of atypical meningioma were reviewed (56% women; median age 61 years; median follow-up 41 months).<br />Results: In patients with GTR, hazard ratio (HR) of PFS was 0.09 for postoperative upfront RT versus observation alone (95% confidence interval [CI] 0.01-0.68; P = .02), though HR for OS was not significant (HR 0.46; 95% CI 0.05-4.45; P = .5). With RT, PFS was 100% at 12 and 36 months (compared to 84% and 63%, respectively, with observation); OS at 36 months (OS36) was 100% (compared to 94% with observation). In patients with STR, though PFS at 36 months was higher for RT arm versus observation (84% vs 74%), OS36 was 100% in both arms. HR was not significant (HR 0.76; 95% CI 0.16-3.5; P = .73).<br />Conclusions: This retrospective study suggests postoperative upfront RT following GTR of atypical meningioma is associated with improved PFS compared to observation. Further studies are required to draw conclusions about OS.<br /> (© The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.)

Details

Language :
English
ISSN :
2632-2498
Volume :
3
Issue :
1
Database :
MEDLINE
Journal :
Neuro-oncology advances
Publication Type :
Academic Journal
Accession number :
34345823
Full Text :
https://doi.org/10.1093/noajnl/vdab094